Publications
5891 Results
- Journal / Conference
- San Antonio Breast Cancer Symposium Annual Meeting (December 9-13, 2014, San Antonio, TX), abstr. [S4-05], oral presentation;
- Year
- 2014
- Research Committee(s)
- Breast
- Study Number(s)
- CTSU/C40603
Impact of intrinsic subtype by PAM50 and other gene signatures on pathologic complete response (pCR) rates with neoadjuvant chemotherapy (NACT) +/- carboplatin (Cb) or bevacizumab (Bev) in triple-negative breast cancer (TNBC):correlative studies from CALGB 40603/CALGB 150709 (Alliance).
- Journal / Conference
- New England Journal of Medicine 371(2):107-118;
- Year
- 2014
- Research Committee(s)
- Breast and Cancer Survivorship
- PMID
- PMID24881463
- PMC
- PMC4175521
Adjuvant exemestane with ovarian suppression in pre-menopausal breast cancer
- Journal / Conference
- San Antonio Breast Cancer Symposium Annual Meeting (December 9-13, 2014, San Antonio, TX), abst. [S3-06], oral;
- Year
- 2014
- Research Committee(s)
- Breast
Mutational analysis of CALGB 40601 (Alliance), a neoadjuvant phase III trial of weekly paclitaxel (T) and trastuzumab (H) with or without lapatinib (L) for HER2-positive breast cancer
- Journal / Conference
- San Antonio Breast Cancer Symposium Annual Meeting (December 9-13, 2014, San Antonio, TX), abstr. [OT2-1-01], poster;
- Year
- 2014
- Research Committee(s)
- Breast
- Study Number(s)
- S1222
Fulvestrant alone versus fulvestrant and everolimus versus fulvestrant, everolimus and anastrozole: A Phase III randomized, placebo-controlled trial in postmenopausal patients with hormone-receptor-positive stage IV breast cancer: SWOG-Clinical Trials Initiative (CTI)* S1222
- Journal / Conference
- Clinical Cancer Research 20(16):4176-4185;
- Year
- 2014
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID24914040
- PMC
- PMC4296727
- Study Number(s)
- S0107, S0205, SWOG-8916, SWOG-8933, SWOG-9100, SWOG-9135, SWOG-9413, S9629, S9924
Historical controls for metastatic pancreatic cancer: benchmarks for planning and analyzing single arm phase II trials
- Journal / Conference
- Journal of Clinical Oncology Vol 32, No 26_suppl, 2014: 36; ASCO Breast Cancer Symposium (September 4-6, 2014, San Francisco, CA);
- Year
- 2014
- Research Committee(s)
- Breast
Recurrence score and clinicopathologic characteristics of TAILORx participants by race and ethnicity
- Journal / Conference
- Journal of Clinical Oncology 32(18):1927-1934
- Year
- 2014
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID24799484
- PMC
- PMC4050205
Capecitabine and oxaliplatin in the preoperative multi-modality treatment of rectal cancer: surgical end points from national surgical adjuvant breast and bowel project trial R-04
- Journal / Conference
- Cancer Epidemiology, Biomarkers and Prevention 23(12):2895-2905;
- Year
- 2014
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- PMID
- PMID25242051
- PMC
- PMC4257858
- Study Number(s)
- S0000
Retention of black and white participants in the Selenium and Vitamin E Cancer Prevention Trial (SWOG-Coordinated Intergroup Study S0000)
- Journal / Conference
- Journal of Urology Vol. 191, No. 4S, Suppl., p. e283 (PD10-04); poster; American Urological Assn Annual Meeting (May 16 -21, 2014, Orlando, FL);
- Year
- 2014
- Research Committee(s)
- Genitourinary
- Study Number(s)
- CTSU/E2805
Lymphadenectomy at the time of surgery for high risk localized RCC: results from the ASSURE adjuvant trial (ECOG 2805)
- Journal / Conference
- Journal of Clinical Oncology 32(suppl 4; abstr LBA287), oral; ASCO GU Cancers Symposium
- Year
- 2014
- Research Committee(s)
- Genitourinary
- Study Number(s)
- CTSU/R0524